Rua Bioscience first NZX IPO of the year

Rua Bioscience first NZX IPO of the year
Brent Melville
Rua Bioscience chair Trevor Burt says the pharmaceutical grade cannabis firm will seek to raise $20 million via a listing on the NZX on Oct. 22 in the first initial public offering of the year. The East Coast based firm - an early recipient for a commercial medicinal production licence - will sell up to 40 million shares at 50 cents a share, representing 28.6 percent of the company in what will be the NZX's first IPO since Napier Port listed last year and the second cannabis firm, following Cannasouth's debut last June. Rua wi...

More Listed Companies

Numbers and letters for investors
Markets

Simon Robertson: Numbers and letters for investors

A plea for standardised financial reporting from NZX-listed companies.

Simon Robertson 02 Mar 2024
Market watchdog puts Fletcher result under microscope
Markets

Market watchdog puts Fletcher result under microscope

Listed firms sitting on material information a theme of NZ RegCo oversight report.

How Gentrack made its India expansion work
Markets

How Gentrack made its India expansion work

Gentrack has more than 100 staff in Pune, India.

NZME boss calls for digital platform law
Listed Companies

NZME boss calls for digital platform law

NZME CEO Michael Boggs calls for government solution to big tech bargaining imbalance.

Daniel Dunkley 21 Feb 2024